发明授权
US08247408B2 Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
失效
用于治疗癌症的PI3Kα吡啶并嘧啶酮抑制剂
- 专利标题: Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer
- 专利标题(中): 用于治疗癌症的PI3Kα吡啶并嘧啶酮抑制剂
-
申请号: US11988859申请日: 2006-10-09
-
公开(公告)号: US08247408B2公开(公告)日: 2012-08-21
- 发明人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Longcheng Wang , Bryan K. S. Yeung
- 申请人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Longcheng Wang , Bryan K. S. Yeung
- 申请人地址: US CA South San Francisco
- 专利权人: Exelixis, Inc.
- 当前专利权人: Exelixis, Inc.
- 当前专利权人地址: US CA South San Francisco
- 代理机构: Honigman Miller Schwartz & Cohn LLP
- 代理商 Heidi M. Berven; Jonathan P. O'Brien
- 国际申请: PCT/US2006/039472 WO 20061009
- 国际公布: WO2007/044698 WO 20070419
- 主分类号: C07D471/04
- IPC分类号: C07D471/04 ; C07D471/14 ; C07D413/14 ; A61K31/519 ; A61K31/5355 ; A61P35/00 ; A61P29/00 ; A61P3/10
摘要:
The invention is directed to Compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
公开/授权文献
- US20090062274A1 Pyridopyrimidinone inhibitors of pi3kalpha 公开/授权日:2009-03-05